Prime Medicine, Inc. PRME Prakiraan Saham
Prediksi harga dan analisis bertenaga AI untuk Prime Medicine, Inc. ยท Diperbarui Apr 17, 2026
Lihat target harga tepat PRME
Buat akun gratis untuk membuka prediksi AI untuk 4.000+ saham
Daftar gratis dengan GoogleGrafik Harga
Statistik Utama
Tentang Prime Medicine, Inc.
Prime Medicine, Inc. (PRME) beroperasi di sektor Life Sciences, khususnya dalam industri Biological Products, (No Diagnostic Substances). .
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Biological Products, (No Diagnostic Substances) Perusahaan Sejenis
| Perusahaan | Ticker | Sinyal AI | Kapitalisasi Pasar | P/E |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | โโ% | $204M | -x |
| Abpro Holdings, Inc. | ABP | โโ% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | โโ% | $880K | -x |
| Arcellx, Inc. | ACLX | โโ% | $6.66B | -x |
| Alpha Cognition Inc. | ACOG | โโ% | $151M | -x |
| Adaptimmune Therapeutics Plc | ADAP | โโ% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | โโ% | $2.62B | 17,8x |
| Adaptive Biotechnologies Corp | ADPT | โโ% | $2.23B | -x |
| Adverum Biotechnologies, Inc. | ADVM | โโ% | $95M | -1,8x |
| Agenus Inc | AGEN | โโ% | $169M | 1471,2x |
| Agentix Corp. | AGTX | โโ% | $2M | -x |
| Aim Immunotech Inc. | AIM | โโ% | $4M | -x |
| Aim Immunotech Inc. | AIMI | โโ% | $1M | -x |
| Alector, Inc. | ALEC | โโ% | $284M | -x |
| Aligos Therapeutics, Inc. | ALGS | โโ% | $41M | -x |
| Allogene Therapeutics, Inc. | ALLO | โโ% | $792M | -x |
| Alvotech | ALVO | โโ% | $1.13B | -x |
| Amgen Inc | AMGN | โโ% | $191.44B | 24,8x |
| Apogee Therapeutics, Inc. | APGE | โโ% | $6.31B | -x |
| Aptose Biosciences Inc. | APTOF | โโ% | $4M | -x |
| Argenx Se | ARGX | โโ% | $52.54B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | โโ% | $421M | -x |
| Artiva Biotherapeutics, Inc. | ARTV | โโ% | $307M | -x |
| Leonabio, Inc. | ATHA | โโ% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | โโ% | $43M | 1,3x |
| Atyr Pharma Inc | ATYR | โโ% | $84M | -x |
| Aura Biosciences, Inc. | AURA | โโ% | $464M | -x |
| Autolus Therapeutics Plc | AUTL | โโ% | $426M | -x |
| Anavex Life Sciences โฆ | AVXL | โโ% | $337M | -x |
| Bioatla, Inc. | BCAB | โโ% | $8M | -x |
| Biocardia, Inc. | BCDA | โโ% | $13M | -x |
| Brainstorm Cell Therapeutics โฆ | BCLI | โโ% | $10M | -x |
| Biocryst Pharmaceuticals Inc | BCRX | โโ% | $2.38B | 9,0x |
| Black Diamond Therapeutics, โฆ | BDTX | โโ% | $175M | 7,8x |
| Beam Therapeutics Inc. | BEAM | โโ% | $3.19B | -x |
| Biogen Inc. | BIIB | โโ% | $26.03B | 20,1x |
| Biontech Se | BNTX | โโ% | $26.03B | -x |
| Cabaletta Bio, Inc. | CABA | โโ% | $346M | -x |
| Candel Therapeutics, Inc. | CADL | โโ% | $467M | -x |
| C4 Therapeutics, Inc. | CCCC | โโ% | $283M | -x |
| Cidara Therapeutics, Inc. | CDTX | โโ% | $6.49B | -1,0x |
| Creative Medical Technology โฆ | CELZ | โโ% | $9M | -x |
| Cero Therapeutics Holdings, โฆ | CERO | โโ% | $1M | -x |
| Cullinan Therapeutics, Inc. | CGEM | โโ% | $907M | -x |
| Compugen Ltd | CGEN | โโ% | $267M | 3,8x |
| Cg Oncology, Inc. | CGON | โโ% | $5.92B | -x |
| Cognition Therapeutics Inc | CGTX | โโ% | $106M | -x |
| Coherus Oncology, Inc. | CHRS | โโ% | $297M | 1,8x |
| Calidi Biotherapeutics, Inc. | CLDI | โโ% | $3M | -x |
| Cellectis S.A. | CLLS | โโ% | $456M | -x |
| Compass Therapeutics, Inc. | CMPX | โโ% | $1.07B | -x |
| Mosaic Immunoengineering Inc. | CPMV | โโ% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | โโ% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | โโ% | $123M | -x |
| Cardiol Therapeutics Inc. | CRDL | โโ% | $169M | -x |
| Curis Inc | CRIS | โโ% | $24M | -x |
| Crispr Therapeutics Ag | CRSP | โโ% | $5.56B | -x |
| Champions Oncology, Inc. | CSBR | โโ% | $84M | -x |
| Cel Sci Corp | CVM | โโ% | $42M | -x |
| Dbv Technologies S.A. | DBVT | โโ% | $1.26B | -x |
| Dbv Technologies S.A. | DBVTF | โโ% | $10K | -x |
| Ginkgo Bioworks Holdings, โฆ | DNA | โโ% | $467M | -x |
| Denali Therapeutics Inc. | DNLI | โโ% | $3.21B | -x |
| Precision Biosciences Inc | DTIL | โโ% | $190M | -x |
| Dyadic International Inc | DYAI | โโ% | $32M | -x |
| Editas Medicine, Inc. | EDIT | โโ% | $342M | -x |
| Eloxx Pharmaceuticals, Inc. | ELOX | โโ% | $560K | -x |
| Elutia Inc. | ELUT | โโ% | $48M | 0,9x |
| Engene Therapeutics Inc. | ENGN | โโ% | $541M | -x |
| Entera Bio Ltd. | ENTX | โโ% | $70M | -x |
| Viskase Holdings, Inc. | ENZN | โโ% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | โโ% | $80M | -x |
| Evaxion A/S | EVAX | โโ% | $37M | -x |
| Exelixis, Inc. | EXEL | โโ% | $11.78B | 15,1x |
| Exozymes Inc. | EXOZ | โโ% | $89M | -x |
| Fate Therapeutics Inc | FATE | โโ% | $160M | -x |
| 4d Molecular Therapeutics, โฆ | FDMT | โโ% | $536M | -x |
| Fennec Pharmaceuticals Inc. | FENC | โโ% | $232M | -x |
| Finch Therapeutics Group, โฆ | FNCH | โโ% | $12M | 0,5x |
| Finch Therapeutics Group, โฆ | FNCHQ | โโ% | $12M | 0,5x |
| Futuretech Ii Acquisition โฆ | FTII | โโ% | $52M | -x |
| Futuretech Ii Acquisition โฆ | FTIIU | โโ% | $14M | -x |
| Gilead Sciences, Inc. | GILD | โโ% | $170.81B | 20,1x |
| Monte Rosa Therapeutics, โฆ | GLUE | โโ% | $1.58B | -x |
| Genenta Science S.P.A. | GNTA | โโ% | $17M | -x |
| Green Planet Bio โฆ | GPLB | โโ% | $340K | -x |
| Greenland Mines Ltd | GRML | โโ% | $51M | -x |
| Halozyme Therapeutics, Inc. | HALO | โโ% | $8.16B | 25,8x |
| Humacyte, Inc. | HUMA | โโ% | $158M | -x |
| Immunitybio, Inc. | IBRX | โโ% | $7.79B | -x |
| Inhibikase Therapeutics, Inc. | IKT | โโ% | $242M | -x |
| Imagenebio, Inc. | IMA | โโ% | $66M | -x |
| Immunocore Holdings Plc | IMCR | โโ% | $1.59B | -x |
| Immatics N.V. | IMTX | โโ% | $1.50B | -x |
| Immunovant, Inc. | IMVT | โโ% | $5.96B | -x |
| In8bio, Inc. | INAB | โโ% | $14M | -x |
| Inhibrx Biosciences, Inc. | INBX | โโ% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | โโ% | $71M | -x |
| Inmune Bio, Inc. | INMB | โโ% | $39M | -x |
| Intensity Therapeutics, Inc. | INTS | โโ% | $13M | -x |
| Iovance Biotherapeutics, Inc. | IOVA | โโ% | $1.59B | -x |
| Century Therapeutics, Inc. | IPSC | โโ% | $467M | -x |
| Invivyd, Inc. | IVVD | โโ% | $491M | -x |
| Jasper Therapeutics, Inc. | JSPR | โโ% | $29M | -x |
| Kalaris Therapeutics, Inc. | KLRS | โโ% | $145M | -x |
| Klotho Neurosciences, Inc. | KLTO | โโ% | $56M | -x |
| Kodiak Sciences Inc. | KOD | โโ% | $2.77B | -x |
| Krystal Biotech, Inc. | KRYS | โโ% | $8.00B | 39,1x |
| Kymera Therapeutics, Inc. | KYMR | โโ% | $7.13B | -x |
| Kyverna Therapeutics, Inc. | KYTX | โโ% | $600M | -x |
| Ladrx Corp | LADX | โโ% | $20K | -x |
| Lineage Cell Therapeutics, โฆ | LCTX | โโ% | $416M | -x |
| Lenz Therapeutics, Inc. | LENZ | โโ% | $319M | -x |
| Liminatus Pharma, Inc. | LIMN | โโ% | $10M | -x |
| Leonabio, Inc. | LONA | โโ% | $83M | -x |
| Lexeo Therapeutics, Inc. | LXEO | โโ% | $504M | -x |
| Maze Therapeutics, Inc. | MAZE | โโ% | $1.39B | -x |
| Mesoblast Ltd | MESO | โโ% | $2.15B | -x |
| Meiragtx Holdings Plc | MGTX | โโ% | $937M | -x |
| Metagenomi Therapeutics, Inc. | MGX | โโ% | $56M | -x |
| Molecular Partners Ag | MOLN | โโ% | $170M | -x |
| Moderna, Inc. | MRNA | โโ% | $21.17B | -x |
| Neurocrine Biosciences Inc | NBIX | โโ% | $13.34B | 27,9x |
| Nkgen Biotech, Inc. | NKGN | โโ% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | โโ% | $375M | -x |
| Novavax Inc | NVAX | โโ% | $1.44B | 3,3x |
| Ocugen, Inc. | OCGN | โโ% | $622M | -x |
| Outlook Therapeutics, Inc. | OTLK | โโ% | $32M | -x |
| Palisade Bio, Inc. | PALI | โโ% | $402M | -x |
| Passage Bio, Inc. | PASG | โโ% | $37M | -x |
| Vaxcyte, Inc. | PCVX | โโ% | $8.17B | -x |
| Biomx Inc. | PHGE | โโ% | $16M | -x |
| Pluri Inc. | PLUR | โโ% | $36M | -x |
| Protalix Biotherapeutics, Inc. | PLX | โโ% | $187M | -x |
| Pharmacyte Biotech, Inc. | PMCB | โโ% | $8M | -x |
| Prime Medicine, Inc. | PRME | โโ% | $688M | -x |
| Prokidney Corp. | PROK | โโ% | $657M | -x |
| Pelthos Therapeutics Inc. | PTHS | โโ% | $74M | -x |
| Qiagen N.V. | QGEN | โโ% | $8.95B | -x |
| Quince Therapeutics, Inc. | QNCX | โโ% | $22M | -x |
| Qrons Inc. | QRON | โโ% | $150K | -x |
| Replimune Group, Inc. | REPL | โโ% | $173M | -x |
| Repligen Corp | RGEN | โโ% | $7.39B | 151,2x |
| Regenxbio Inc. | RGNX | โโ% | $483M | -x |
| Relay Therapeutics, Inc. | RLAY | โโ% | $2.91B | -x |
| Revolution Medicines, Inc. | RVMD | โโ% | $29.28B | -x |
| Recursion Pharmaceuticals, Inc. | RXRX | โโ% | $2.00B | -x |
| Sab Biotherapeutics, Inc. | SABS | โโ% | $271M | 20,4x |
| Sana Biotechnology, Inc. | SANA | โโ% | $939M | -x |
| Scilex Holding Co | SCLX | โโ% | $49M | -x |
| Scinai Immunotherapeutics Ltd. | SCNI | โโ% | $2M | -x |
| Sangamo Therapeutics, Inc | SGMO | โโ% | $108M | -x |
| Solid Biosciences Inc. | SLDB | โโ% | $849M | -x |
| Silexion Therapeutics Corp | SLXN | โโ% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | โโ% | $34M | -x |
| Scholar Rock Holding โฆ | SRRK | โโ% | $5.42B | -x |
| Surrozen, Inc./De | SRZN | โโ% | $371M | -x |
| Sutro Biopharma, Inc. | STRO | โโ% | $523M | -x |
| Protara Therapeutics, Inc. | TARA | โโ% | $292M | -x |
| Tarsus Pharmaceuticals, Inc. | TARS | โโ% | $2.86B | -x |
| Tc Biopharm (Holdings) โฆ | TCBPY | โโ% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | โโ% | $68M | -x |
| Bio-Techne Corp | TECH | โโ% | $9.23B | 113,8x |
| Tectonic Therapeutic, Inc. | TECX | โโ% | $553M | -x |
| Instil Bio, Inc. | TIL | โโ% | $60M | -x |
| Tenaya Therapeutics, Inc. | TNYA | โโ% | $170M | -x |
| Tourmaline Bio, Inc. | TRML | โโ% | $1.23B | -3,5x |
| Taysha Gene Therapies, โฆ | TSHA | โโ% | $1.83B | -x |
| Titan Pharmaceuticals Inc | TTNP | โโ% | $6M | -0,5x |
| Tevogen Bio Holdings โฆ | TVGN | โโ% | $31M | -x |
| Twist Bioscience Corp | TWST | โโ% | $3.66B | -x |
| Voyager Acquisition Corp./Cayman โฆ | VACH | โโ% | $407M | 45,3x |
| Voyager Acquisition Corp./Cayman โฆ | VACHU | โโ% | $68M | 6,7x |
| Valneva Se | VALN | โโ% | $535M | -x |
| Vericel Corp | VCEL | โโ% | $1.81B | 109,3x |
| Vir Biotechnology, Inc. | VIR | โโ% | $1.73B | -x |
| Vivosim Labs, Inc. | VIVS | โโ% | $4M | -x |
| Vor Biopharma Inc. | VOR | โโ% | $810M | -x |
| Vaxart, Inc. | VXRT | โโ% | $180M | 11,1x |
| Voyager Therapeutics, Inc. | VYGR | โโ% | $244M | -x |
| Windtree Therapeutics Inc โฆ | WINT | โโ% | $670K | -x |
| X4 Pharmaceuticals, Inc | XFOR | โโ% | $390M | -x |
| Zeo Scientifix, Inc. | ZEOX | โโ% | $14M | -x |
| Zivo Bioscience, Inc. | ZIVO | โโ% | $8M | -x |
| Zura Bio Ltd | ZURA | โโ% | $551M | -x |
FAQ
-
Apakah Prime Medicine, Inc. saham yang bagus untuk dibeli?
AI kami menganalisis Prime Medicine, Inc. setiap hari. Periksa sinyal di atas untuk rekomendasi terbaru. Selalu lakukan riset sendiri sebelum berinvestasi.
-
Seberapa akurat prediksi Prime Medicine, Inc.?
AI kami mencapai korelasi Spearman 24% untuk saham ini, dengan akurasi rata-rata di atas 67% untuk 4.000+ saham yang dianalisis setiap hari.
-
Seberapa sering prakiraan diperbarui?
Prakiraan Prime Medicine, Inc. diperbarui setiap hari menggunakan data pasar terbaru dan model AI.
Siap berinvestasi lebih cerdas?
Bergabunglah dengan ribuan investor yang menggunakan prediksi saham bertenaga AI
Daftar GratisMencari analisis lebih mendalam tentang Prime Medicine, Inc.?
Lihat analisis tingkat institusional lengkap di Intratio โPrediksi AI didasarkan pada pola historis dan tidak boleh menjadi satu-satunya dasar untuk keputusan investasi. Kinerja masa lalu tidak menjamin hasil di masa depan. Selalu lakukan riset sendiri.